Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Gavvovidis, Ioannis Dr. (1) Hinz, Michael Dr. (1) Höpken, Uta Elisabeth PD Dr. (1) Leisegang, Matthias Dr. (7) Müller, Gerd Dr. (1) Na, Il-Kang Dr. (1) Nguyen, Tam Hoai Dr. (1) Pezzutto, Antonio Prof. Dr. (9) Uckert, Wolfgang Prof. Dr. (16) Willimsky, Gerald Dr. (1) Yilmaz, Zekiye Buket Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (5) (-) Daumke, Oliver Prof. Dr. (1) (-) Kopp, Joachim Dr. (2) (-) Lorenz, Felix Dr. (1) (-) Obenaus, Matthias (1) Biologie maligner Lymphome (8) Hypertonie-vermittelter Endorganschaden (1) Hypertonie bedingte Endorganschäden (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) Molekulare Immunologie und Gentherapie (10) (-) Molekulare Immuntherapie (3) (-) Molekulare Zellbiologie und Gentherapie (4) Signaltransduktion in Tumorzellen (1) Strukturbiologie Membran-assoziierter Prozesse (11) Systembiologie von Gen-regulatorischen Elementen (1) 1997 (2) 1998 (4) 1999 (1) 2000 (4) 2003 (5) 2004 (2) 2005 (5) 2006 (2) 2007 (3) 2008 (1) (-) 2010 (2) 2011 (3) 2013 (2) 2014 (1) (-) 2015 (5) 2016 (3) 2017 (2) 2018 (1) 2019 (3) 2021 (1) 7 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Daumke, Oliver Prof. Dr.Kopp, Joachim Dr.Lorenz, Felix Dr.Obenaus, MatthiasMolekulare ImmuntherapieMolekulare Zellbiologie und Gentherapie20102015 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. August 2015 in Mol Oncol Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma F. Oden S.F. Marino J. Brand S. Scheu C. Kriegel D. Olal A. Takvorian J. Westermann B. Yilmaz M. Hinz O. Daumke U.E. Höpken G. Müller M. Lipp 15. April 2015 in Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann 01. April 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber 01. April 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein 23. März 2015 in PLoS ONE Codon optimization of the human papillomavirus E7 oncogene induces a CD8(+) T cell response to a cryptic epitope not harbored by wild-type E7 F.K.M. Lorenz S. Wilde K. Voigt E. Kieback B. Mosetter D.J. Schendel W. Uckert 15. April 2010 in Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner 01. März 2010 in Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
01. August 2015 in Mol Oncol Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma F. Oden S.F. Marino J. Brand S. Scheu C. Kriegel D. Olal A. Takvorian J. Westermann B. Yilmaz M. Hinz O. Daumke U.E. Höpken G. Müller M. Lipp
15. April 2015 in Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
01. April 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
01. April 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
23. März 2015 in PLoS ONE Codon optimization of the human papillomavirus E7 oncogene induces a CD8(+) T cell response to a cryptic epitope not harbored by wild-type E7 F.K.M. Lorenz S. Wilde K. Voigt E. Kieback B. Mosetter D.J. Schendel W. Uckert
15. April 2010 in Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
01. März 2010 in Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
